Stock PRTG PORTAGE BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.237 USD -5.28% Intraday chart for Portage Biotech Inc. -1.25% -86.98%
Apr. 15 Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives CI
Apr. 12 Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives CI

Chart calendar Portage Biotech Inc.

f16f5cf0554fdd5.jhZ9DqTXnYH_1SzUxQaTzI1SaiEQkaGyIAJgk1aJA84.4yMSf5eQ5OXPll2Dr0n7qegDGnJ969PIWEEm-2P-R53-XTxqlKelxom8Sw~d73a15be9ae27ac6d22b2413e695e9d7

Upcoming events on Portage Biotech Inc.

2024-07-28 Q4 2024 Earnings Release (Projected)
2024-08-25 Q1 2025 Earnings Release (Projected)
2024-11-25 Q2 2025 Earnings Release (Projected)
2025-02-25 Q3 2025 Earnings Release (Projected)

Past events on Portage Biotech Inc.

2024-02-28 05:10 pm Q3 2024 Earnings Release
2023-11-28 04:01 pm Q2 2024 Earnings Release
2023-09-28 10:20 am Cantor Global Healthcare Conference
2023-09-11 H.C. Wainwright Global Investment Conference
2023-08-30 08:00 am Q1 2024 Earnings Release
2023-07-31 04:05 pm Q4 2023 Earnings Release
2023-06-08 10:15 am BIO International Convention - Panel
2023-03-14 02:00 pm Oppenheimer Healthcare Conference
2023-03-09 10:30 am Investor Meeting - Key Opinion Leader
2023-03-01 08:00 am Q3 2023 Earnings Release
2023-02-22 09:00 am Citi Virtual Oncology Leadership Summit
2022-11-29 04:43 pm Interim 2023 Earnings Release
2022-11-10 10:30 am Annual General Meeting
2022-11-10 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract No. - 745
2022-08-29 08:00 am Q1 2023 Earnings Release
2022-08-01 08:00 am FY 2022 Earnings Release
2022-07-07 08:30 am Acquisition of Tarus Therapeutics by Portage Biotech, Inc Call
2022-06-05 American Society of Clinical Oncology Meeting - Abstract Number: 2520
2022-06-05 American Society of Clinical Oncology Meeting - Abstract Number: 11515
2022-06-05 American Society of Clinical Oncology Meeting - Abstract Number: 382017

Annual results

Fiscal PeriodMarch 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-15,6
-15,3
-1.84%		-16,6
-18,0
7.92%
-19,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-14,8
-15,1
2.19%		-123
-18,0
-580.68%
-62,4

Net income
Million USD		Released
Forecast
Spread 		-16,9
-13,7
-22.75%		-105
-16,0
-553.82%
-51,8

EPS
USD		Released
Forecast
Spread 		-1,29
-1,05
-22.86%		-6,49
-0,94
-590.43%
-2,72

Announcement Date01/08/2231/07/23-

Quarterly results

Fiscal PeriodMärz 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,17
-3,60
-15.81%		-4,50
-4,24
-6%		-4,09
-4,38
6.67%		-3,65
-4,20
13.04%		-4,76
-3,88
-22.75%		-4,08
-5,00
18.48%		-5,00
-4,18
-19.62%		-5,93
-4,63
-27.99%		-4,03
-5,84
31.06%
-4,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,09
-4,00
-2.23%		-4,05
-4,26
5.08%		-4,18
-4,35
3.87%		-3,64
-4,53
19.77%		-5,30
-3,88
-36.76%		-109
-5,00
-2088.1%		-6,07
-4,18
-45.33%		-6,07
-4,63
-31.06%		-48,9
-5,82
-740.07%
-4,35

Net income
Million USD		Released
Forecast
Spread 		-3,51
-3,78
7.04%		-7,32
-3,78
-93.83%		-1,73
-4,05
57.26%		-0,95
-4,53
79.07%		-7,49
-3,88
-93.06%		-94,4
-5,00
-1788.96%		-5,92
-4,18
-41.69%		-5,16
-4,63
-11.33%		-39,4
-5,82
-576.74%
-4,35

EPS
USD		Released
Forecast
Spread 		-0,26
-0,27
4.88%		-0,55
-0,28
-98.79%		-0,13
-0,30
56.18%		-0,06
-0,29
79.31%		-0,44
-0,23
-95.56%		-6,00
-0,27
-2122.22%		-0,33
-0,24
-37.5%		-0,29
-0,27
-7.41%		-1,88
-0,27
-596.3%
-0,22

Announcement Date24/02/2201/08/2229/08/2229/11/2201/03/2331/07/2329/08/2328/11/2328/02/24-

Upcoming sector events for Portage Biotech Inc.

2024-04-26 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-28 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-28 MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-29 04:05 pm QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Portage Biotech Inc.

Today 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
Today BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
Today PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
Today HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
Today BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
Today CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 07:00 am MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
2024-04-25 02:00 am PURETECH HEALTH PLC: Q4 2023 Earnings Release
2024-04-24 FORMYCON AG: Q4 2023 Earnings Release
2024-04-24 PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PRTG Stock
  4. Calendar Portage Biotech Inc.